EGFR/ErbB-2 Inhibitor,
179248-61-4,
4557W,
4-(4-Benzyloxyanilino)-6,7-dimethoxyquinazoline,
SCHEMBL242224,
CHEMBL563845,
GTPL5964,
CTK8E8822,
DTXSID40431718,
HMS3229C21,
ZINC1485577,
HSCI1_000238,
IN1350,
AKOS002350936,
CCG-206748,
RT-012453,
J-011438,
BRD-K76819286-001-01-0,
N-[4-(benzyloxy)phenyl]-6,7-dimethoxyquinazolin-4-amine,
N-[4-(Benzyloxy)phenyl]-6,7-dimethoxyquinazoline-4-amine,
4-Quinazolinamine, 6,7-dimethoxy-N-[4-(phenylmethoxy)phenyl]-,
6,7-Dimethoxy-N-[4-(phenylmethoxy)phenyl]-4-quinazolinamine,
D0X4OU,
CID9843206,
6,7-dimethoxy-N-(4-phenylmethoxyphenyl)quinazolin-4-amine,